Telomir Pharmaceuticals Inc (TELO) - News Archive

TAMPA, Fla., July 02, 2024 - Telomir Pharmaceuticals, Inc. (Nasdaq: TELO), a pre-clinical-stage pharmaceutical company specializing in the development and commercialization of Telomir-1, a revolutionary small molecule a...

Telomir Pharmaceuticals, a leading biopharmaceutical company, is thrilled to announce two significant milestones in the development of their flagship product candidate, Telomir-1. The company has commenced a groundbreak...

The press release highlights that the upcoming poster presentation at the conference will unveil the promising results of Telomir-1 in elongating telomere caps on human normal embryonic fibroblast cells. These telomere...

In the perpetual pursuit of the fountain of youth, Telomir Pharmaceuticals is pioneering a groundbreaking approach to age reversal science. Leveraging the power of artificial intelligence (AI) testing models, the compan...

Telomir Pharmaceuticals Presents Exciting Pre-Clinical Data on Telomir-1 at Singapore ConferenceTelomir Pharmaceuticals, in collaboration with Frontage Laboratories, recently unveiled groundbreaking pre-clinical data on...